These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7514393)

  • 1. Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers.
    Sitzmann JV; Wu Y; Cameron JL
    Ann Surg; 1994 May; 219(5):500-6; discussion 506-7. PubMed ID: 7514393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer.
    Wu Y; Cahill PA; Sitzmann JV
    Ann Surg; 1996 Feb; 223(2):225-31. PubMed ID: 8597519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular density and VEGF expression in hepatic lesions.
    Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of growth hormone receptor mRNA in hepatocellular carcinoma and matched para-cancer cirrhotic liver tissue].
    Wang HT; Wang J; Ou QJ; Liu XP; Chen S
    Ai Zheng; 2002 Feb; 21(2):146-8. PubMed ID: 12479063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor.
    Yoshiji H; Kuriyama S; Fukui H
    Tumour Biol; 2002; 23(6):348-56. PubMed ID: 12677092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation.
    Campillo A; Solanas E; Morandeira MJ; Castiella T; Lorente S; Garcia-Gil FA; Piazuelo E; de Martino A; Serrano MT
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):871-9. PubMed ID: 24922356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis.
    Mouta Carreira C; Nasser SM; di Tomaso E; Padera TP; Boucher Y; Tomarev SI; Jain RK
    Cancer Res; 2001 Nov; 61(22):8079-84. PubMed ID: 11719431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
    Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
    J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
    Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
    Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.
    Bedossa P; Peltier E; Terris B; Franco D; Poynard T
    Hepatology; 1995 Mar; 21(3):760-6. PubMed ID: 7875675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facing the enigma of the vascular network in hepatocellular carcinomas in cirrhotic and non-cirrhotic livers.
    Vasuri F; Fittipaldi S; Giunchi F; Monica M; Ravaioli M; Degiovanni A; Bonora S; Golfieri R; Bolondi L; Grigioni WF; Pasquinelli G; D'Errico-Grigioni A
    J Clin Pathol; 2016 Feb; 69(2):102-8. PubMed ID: 26243063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function considerations for post-selective internal radiation therapy resection (hepatocellular carcinoma and metastatic colorectal cancer).
    Sangro B
    Future Oncol; 2014 Nov; 10(15 Suppl):57-9. PubMed ID: 25478769
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of uptake of indocyanine green and trypan blue by hepatocellular carcinoma.
    Itoshima T; Ito T; Ukida M; Ogawa H; Kitadai M; Hattori S; Mizutani S; Kita K; Tanaka R; Koide N
    Acta Med Okayama; 1984 Feb; 38(1):65-9. PubMed ID: 6322526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
    Zhao A; Dou K; Li K; Fu Y
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered dynamics of alpha-fetoprotein production following pyridoxine and adenosine 5'-triphosphate administration to cirrhotic patients with or without primary hepatomas and to liver-injured and hepatoma-bearing rats.
    Watanabe A; Nagashima H
    Oncodev Biol Med; 1981; 2(5):313-21. PubMed ID: 6173868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats.
    Kaji K; Yoshiji H; Kitade M; Ikenaka Y; Noguchi R; Shirai Y; Aihara Y; Namisaki T; Yoshii J; Yanase K; Tsujimoto T; Kawaratani H; Fukui H
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1094-104. PubMed ID: 21372165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.